Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $150.24M.
ENTERPRISE VALUE (EV)
$150.24M
Yarrow Bioscience Inc
Market Cap
$174.27M
Enterprise Value (EV)
$150.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Yarrow Bioscience Inc (YARW) | $174.27M | $150.24M |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | $55.10M |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | $193.28M |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | $113.15M |
| Journey Medical Corporation (DERM)vs › | $169.53M | $169.43M |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | $164.74M |
| MediWound Ltd. (MDWD)vs › | $168.92M | $174.11M |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | $153.93M |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | $159.51M |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | $143.23M |
Market Cap
$174.27M
Total Debt
$0.00
Cash
$24.03M
Enterprise Value
$150.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
